Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Efficacy and safety of spirapril in mild-to-moderate hypertension

Class:IdLiteratureReference:9615089
_displayNameEfficacy and safety of spirapril in mild-to-moderate hypertension
_timestamp2018-07-31 09:26:34
author[Person:9615106] Hayduk, K
[Person:9615111] Kraul, H
created[InstanceEdit:9615129] Jassal, Bijay, 2018-07-31
journalJ. Cardiovasc. Pharmacol.
pagesS19-23
pubMedIdentifier10499560
titleEfficacy and safety of spirapril in mild-to-moderate hypertension
volume34
year1999
(literatureReference)[ChemicalDrug:9614961] spiraprilat [extracellular region]
[ChemicalDrug:9619016] spirapril [endoplasmic reticulum lumen]
[ChemicalDrug:9619049] spiraprilat [endoplasmic reticulum lumen]
[Summation:9614951] Angiotensin-converting enzyme (ACE) is a central component o...
[Change default viewing format]
No pathways have been reviewed or authored by Efficacy and safety of spirapril in mild-to-moderate hypertension (9615089)